- FTC Staff Opinion: University of Michigans Proposed Rx Program Exempt From Robinson-Patman Act ( )
- FTC Provides Comments to FCC on Protecting Children in Traditional and New Media Environments; FTC Approves Final Settlement Order Regarding The M Group, Inc., Doing Business As Bamboosa; FTC Approves Final Settlement Order Regarding Roaring Fork Valley ( )
- FTC Approves Final Settlement Orders Regarding Boulder Valley IPA and M. Catherine Higgins; Commission Submits Comments on Measuring the Performance of Electric Regional Transmission Organizations and on FERCs Method of Assessing Partial Acquisitions ( )
- Commission Approves Carilion Clinic's Application to Sell Center for Surgical Excellence to Fairlawn Surgery Center, LLC ( )
- Statement by FTC Chairman Jon Leibowitz Regarding Today’s District Court Decision Denying a Motion to Dismiss the Commission’s Pay-For-Delay Case Against Cephalon Inc. ( )
- FTC Approves Final Settlement Order Regarding Danaher Corporation and MDS, Inc. ( )
- Statement by FTC Chairman Jon Leibowitz Regarding Continuing Need for Legislation Banning Illegal Pay-for-Delay Drug Settlements ( )
- Statement of Federal Trade Commission Chairman Jon Leibowitz on Ending Pay-for-Delay Drug Settlements, Praises Inclusion in Presidents Health Care Proposal ( )
- FTC Warns Marketers of Children's Omega-3 Fatty Acid Supplements That Claims About Brain and Vision Benefits May Be Deceptive ( )
- FTC Settles Charges That Colorado Physicians Group Director Attempted to Evade Terms of 2008 Price-Fixing Order ( )
- Colorado Physicians Group Agrees to Stop Alleged Price-Fixing Tactics ( )
- Commission Approves FY 2011 Budget Request and GPRA Performance Plans for Submission to Congress; FTC Staff: Proposed Kentucky Regulations for Licensing Retail Clinics Raise Competitive Concerns; FTC Issues Annual Financial Acts Enforcement Report to ( )
- FTC Approves Final Consent Order in Case of Pfizer Inc. and Wyeth ( )
- FTC Order Preserves Competition in Market for Important Scientific Research Device, While Allowing Danaher to Proceed with Purchase of MDS Analytical Technologies ( )
- Commission Seeks Public Comments on Carilion Clinics Application to Divest Center for Surgical Excellence to Fairlawn Surgery Center, LLC; FTC Approves The Dow Chemical Companys Petition to Divest its Acrylic Acid and Latex Polymers Businesses to Arkema ( )
- Commission Announces Revised Filing Thresholds for Clayton Act Antitrust Reviews; Commission Retains Amplifier Rule; Final Consent Orders against Six Businesses That Claimed to Comply With an International Privacy Framework ( )
- FTC Chairman, Members of Congress Call for Legislation to End Sweetheart Pay-for-Delay Deals That Keep Generic Drugs Off the Market ( )
- Bureau of Competition Director Issues Statement on FTCs Closure of its Investigation of Consummated Hospital Merger in Temple, Texas ( )
- FTC Order Ensures Future Competition for Parkinsons and Chemotherapy Drugs That Watsons Acquisition of Arrow Would Have Eliminated ( )
- Commission Issues 2009 Report on U.S. Ethanol Market Concentration; FTC Approves Final Consent Order in Matter Concerning Carilion Clinic ( )
- Statement of FTC Chairman Jon Leibowitz On Passage of H.R. 3126, the Consumer Financial Protection Act of 2009 by the House Energy and Commerce Committee ( )
- FTC Order Restores Competition Lost Through Schering-Plough's Acquisition of Merck ( )
- U.S. Court of Appeals Enforces Subpoenas in FTCs Androgel Investigation; In Separate Case, FTC Files Petition to Compel Enforcement of Subpoena Issued to Boehringer Ingelheim ( )
- Statement of FTC Chairman Jon Leibowitz Regarding the Senate Judiciary Committee's Passage of the Preserve Access to Affordable Generics Act (S. 369) ( )
- FTC Order Prevents Anticompetitive Effects from Pfizers Acquisition of Wyeth ( )
- Commission Order Restores Competition Eliminated by Carilion Clinics Acquisition of Two Outpatient Clinics ( )
- Bureau of Competition Statement Regarding the Announcement that Thoratec Corporation Will Not Proceed with Its Proposed Acquisition of HeartWare International ( )
- Statement by FTC Chairman Jon Leibowitz on Adoption of the Pay for Delay Amendment to the Americas Affordable Health Choices Act of 2009 by the House Energy and Commerce Committee ( )
- FTC Challenges Thoratec's Proposed Acquisition of HeartWare International ( )
- FTC Challenges Carilions Acquisition of Outpatient Medical Clinics ( )
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.